SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently a focal point for investors following multiple high-profile partnerships, including a collaboration with NVIDIA on a Sovereign AI OS and expanded defense sector engagements. The community is buzzing about the company's accelerating role in AI-driven intelligence and military applications amid rising geopolitical tensions, while also actively debating its valuation and short-term price action.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is trending following its strong earnings beat, first GAAP profitability, and a new substantial stock buyback, sparking community debate over conservative growth guidance versus perceived market manipulation by shorts and the potential for a 'Palantir moment' with government AI contracts.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending with high anticipation ahead of the upcoming OFC Conference, where it will showcase its advanced optical engines for AI applications in a significantly expanded booth. Community speculation about potential major partnerships, especially after Marvell's acquisition of a POET customer, is fueling a strong bullish sentiment across the heating photonics sector.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas (ONDS) is trending following a strategic partnership with Palantir and World View to advance AI-enabled multi-domain intelligence platforms, alongside the acquisition of BIRD Aerosystems, significantly expanding its defense capabilities. While many are bullish, anticipating a substantial short squeeze and future growth in the defense sector, the community is actively debating the impact of frequent dilution and the stock's muted reaction to otherwise significant developments.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending due to its newly announced development agreement with Tower Semiconductor, which the community widely interprets as a critical step toward integrating its advanced polymer modulators into the NVIDIA supply chain. This partnership is fueling immense investor optimism that validates LWLG's technology for the rapidly expanding AI and data center photonics market, signaling a path to significant commercial adoption and substantial growth.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending following a Hunterbrook article positioning it as a "stealth supplier" for NVIDIA's AI optics revolution and TSMC's CPO platform, sparking intense community debate between bullish long-term CPO potential and warnings of a pump and dump amid volatile trading.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending amidst escalating geopolitical tensions, driven by Iran's threats to keep the Strait of Hormuz closed and surging oil prices, sparking community debate over market manipulation and global economic stability.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending following an investor day where its new AI assistant reportedly bombed, alongside mixed Q4 earnings showing widening losses despite revenue growth. The community is actively discussing the confirmed plans for future capital raises and registered shares for resale, fueling concerns about ongoing dilution and the company's challenging path to profitability in the competitive luxury EV market.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending due to newly reported manufacturing issues concerning wiring flaws that may delay 737 MAX deliveries, fueling concerns over quality control and commercial sector headwinds. Conversely, community discussions also highlight a robust defense segment benefiting from increased geopolitical tensions and the anticipation of a major aircraft order from China.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Escalating US-Iran tensions, highlighted by Iran's new Supreme Leader threatening to keep the Strait of Hormuz closed and fresh reports of tanker attacks, are fueling community debate on whether record oil reserve releases can effectively counter the critical global supply disruption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Issues Pessimistic Estimate for DRTS Earnings

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Investment analysts at HC Wainwright cut their Q1 2026 EPS estimates for shares of Alpha Tau Medical in a research report issued on Tuesday, March...

Citigroup Increases Alpha Tau Medical (NASDAQ:DRTS) Price Target to $9.00

Citigroup boosted their price target on shares of Alpha Tau Medical from $7.00 to $9.00 and gave the company a "buy" rating in a research note on Wednesday...

HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS)

HC Wainwright restated a "buy" rating and set a $12.00 price objective on shares of Alpha Tau Medical in a research report on Tuesday...

Alpha Tau Medical (NASDAQ:DRTS) Issues Earnings Results, Misses Estimates By $0.01 EPS

Alpha Tau Medical (NASDAQ:DRTS - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.14) earnings per share for the quarter, missing analysts' consensus...

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from Brokerages

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) has been given an average recommendation of "Hold" by the five analysts that are currently covering the company, Marketbeat Ratings reports. One...

Piper Sandler Reiterates Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS)

Piper Sandler reissued a "neutral" rating and issued a $5.00 price objective on shares of Alpha Tau Medical in a research report on Wednesday...

Alpha Tau Medical (DRTS) Expected to Announce Quarterly Earnings on Wednesday

Alpha Tau Medical (NASDAQ:DRTS) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 11. (View Earnings Report at...

Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year High - What's Next?

Alpha Tau Medical (NASDAQ:DRTS) Sets New 52-Week High - Time to Buy...

Alpha Tau Medical (NASDAQ:DRTS) Upgraded at Zacks Research

Zacks Research raised Alpha Tau Medical from a "strong sell" rating to a "hold" rating in a report on Tuesday...

Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Rises By 111.0%

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totaling 527,362...

$DRTS Q4 &#39;25 Earnings Results &amp; Recap

Alpha Tau Medical expects to incur substantial losses and increasing expenses for the foreseeable future, requiring significant additional funding for clinical trials, manufacturing expansion, and commercialization efforts over the next several years.

Stocktwits

ALPHA TAU MEDICAL LTD

 Q4 '25 Earnings Results & Recap

Alpha Tau Medical expects to incur substantial losses and increasing expenses for the foreseeable future, requiring significant additional funding for clinical trials, manufacturing expansion, and commercialization efforts over the next several years.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

Excitement grows over the groundbreaking Alpha DaRT technology securing marketing approval in Japan, a key de-risking event alongside active US clinical trials.

The Q4 earnings report confirms a robust $76.9M in cash and zero debt, providing ample funding for clinical milestones and removing near-term dilution concerns.

Analysts like Citi and H.C. Wainwright are raising price targets to $9-$12, yet many believe these valuations still undervalue the company's potential.

Many traders view the current stock price below $7 as a strong accumulation opportunity, anticipating a significant re-valuation given its unique oncology technology.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.12	--	--	N/A
Q4 '25	-$0.12	--	--	N/A
Q3 '25	-$0.12	--	--	N/A
Q2 '25	-$0.11	-$0.13	-17.33%	MISSED
Q1 '25	-$0.13	-$0.12	5.90%	BEAT

DRTS
ALPHA TAU MEDICAL LTD

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest DRTS News

DRTSALPHA TAU MEDICAL LTD